What are the treatment options for chronic lymphocytic leukaemia?

CLL can change slowly for some people, so treatment is not always started immediately after diagnosis. The team considers troublesome symptoms, enlarged lymph nodes or spleen, falling blood counts, repeated infections, and changes shown by blood tests. Active monitoring includes planned reviews rather than ignoring the condition.

Targeted therapy blocks signals or processes that CLL cells rely on. Chemotherapy uses medicines that damage dividing cancer cells and may be combined with another treatment. The choice can be influenced by chromosome or gene findings, other health conditions, medicines you take, and your preferences.

Keep a record of fevers, night sweats, weight change, infections, bruising, tiredness, and swollen areas. Give the team a complete medicine and supplement list. Ask how treatment could affect infection risk, vaccinations, work, and travel, and what symptoms should be reported between appointments.

If monitoring is recommended, agree on the review schedule and the blood-test changes that would prompt a new discussion. During treatment, take medicines exactly as prescribed and tell the team about missed doses or new side effects.

Seek prompt medical advice for a fever, chills, a new cough, breathlessness, painful urination, unusual bleeding, or rapidly increasing weakness. Contact the treatment team urgently for severe allergic symptoms, confusion, or an infection that is worsening.

Do I need treatment now, or is monitoring appropriate? Which blood or genetic findings affect my options? Why is this targeted medicine or chemotherapy being suggested? How will you protect me from infections, and how will response be checked?